Valore20202021202220232024TTMSpese di vendita, generali e amministrative8.85 B10.54 B7.78 B8.66 B8.51 B8.28 BRicerca e sviluppo——————Reddito operativo-5.04 B2.04 B4.38 B3.91 B4.42 B5.65 BProventi non operativi, Totale223 M259 M497 M132 M202 M169 MOneri finanziari, al netto degli interessi capitalizzati217 M178 M248 M252 M265 M231 MProventi non operativi, esclusi gli oneri finanziari-24 M-22 M-30 M-154 M-25 M209 MEntrate/uscite straordinarie30 M103 M279 M34 M-38 M—Utile al lordo delle imposte-5.03 B1.93 B4.63 B3.79 B4.36 B5.59 BQuota di utile48 M43 M5 M4 M9 M—Imposte-695 M636 M905 M629 M878 M1.04 BInteressi di minoranza199 M173 M162 M158 M186 M210 MAltri proventi/oneri al netto delle imposte-188 M-501 M-298 M-233 M-424 M-422 MUtile netto al lordo delle attività cessate-4.54 B1.12 B3.56 B3 B3.29 B4.34 BAttività cessate-1 M-5 M-3 M00—Utile netto-4.54 B1.11 B3.56 B3 B3.29 B4.34 BRegolazione della diluizione——————Dividendi privilegiati——————Utile netto diluito attribuibile agli azionisti ordinari-4.54 B1.11 B3.56 B3 B3.29 B4.34 BUtile base per azione (EPS base)-28.267.3225.2322.5425.8634.82Utile diluito per azione (EPS diluito)-28.267.2325.0322.3925.7234.66Numero medio di azioni ordinarie in circolazione160.6 M152.3 M141.1 M133.2 M127.4 M499.5 MAzioni diluite in circolazione160.6 M154.1 M142.2 M134.1 M128.1 M501.7 MEBITDA-4.7 B2.35 B4.65 B4.19 B4.69 B6.34 BEBIT-5.04 B2.04 B4.38 B3.91 B4.42 B5.65 BCosto del fatturato226.08 B250.84 B264.35 B296.12 B345.73 B383.81 BAltri costi del venduto——————Ammortamento e svalutazione (liquidità)344 M312 M272 M279 M272 M684 M
McKesson Corporation
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.